Combined treatment with two cancer immunotherapy drugs — one a novel immune modulator and one that focuses and activates the antitumor immune response — significantly prolonged survival in mouse
models of the aggressive cancer malignant mesothelioma.
Not exact matches
A team
of researchers from the Hyperbaric Biomedical Research Laboratory at the University
of South Florida (USF) doubled survival time in an
aggressive metastatic
cancer model using a novel combination
of non-toxic dietary and hyperbaric oxygen therapies.
Recently, teaming up with co-investigator Associate Professor Dr. Rolf A. Brekken, they looked into its possible involvement in Pancreatic Ductal Adenocarcinoma (PDA), the most common form
of pancreatic
cancer, in a mouse
model with an early onset
aggressive form
of tumor development.
In a new study published in Scientific Reports, Tokyo Medical and Dental University (TMDU)- led researchers investigated photodynamic detection
of cancer stem cells in a glioma cell line, a
model of a highly
aggressive type
of brain
cancer.
They found that, by using math
models to understand the complex dynamics within
cancers, they could use small changes in the environment to promote the growth
of cells that are less
aggressive and thereby decrease tumor growth.
In the meantime, he adds, gaining a better understanding
of aggressive NF1 - related tumors allows researchers to develop more realistic
models of these
cancers in the lab.
A new study shows coibamide A has potent anti-
cancer activity in mice and cell cultures that
model brain tumors and triple negative breast
cancer, two
of the most
aggressive and difficult - to - treat types
of cancer.
«BMI1 plays a substantial role in many solid tumors, including one
of the most
aggressive models of lung
cancer, and its expression is linked with tumor growth, invasion, metastasis, prognosis and recurrence,» Levantini said.
A new urine - based test improved prostate
cancer detection — including detecting more
aggressive forms
of prostate
cancer — compared to traditional
models based on prostate serum antigen, or PSA, levels, a new study finds.
The first accurate mouse
model of an
aggressive childhood muscle
cancer has improved researchers» understanding
of the cause
of the disease and could accelerate the identification
of new...
Cutaneous SCC is a clinically
aggressive cancer, and the inactivation
of p21waf1 / cip1 has been shown to play a critical role in the formation
of skin tumor in knockout mice
models (14, 15).
This
model should be a powerful tool for testing therapies for
aggressive ER + breast
cancers and for studying luminal
cancers — the most prevalent and deadliest forms
of breast
cancer.